Novartis today confirmed the plan to spin off 100% of its generic drugs arm Sandoz, with trading of the new company’s shares as well as ADRs (American Depositary Receipts...
As Novartis moves toward shedding generics subsidiary Sandoz, which it touts as a global leader in off-patent generic and biosimilar drugs, Sandoz has agreed a multi-year...
In advance of the planned spinoff of generics subsidiary Sandoz into a standalone generics producer, Novartis has announced it is closing one of the subsidiary’s US...
08.04.2020
- In early March, the Indian government asserted that the coronavirus epidemic in China was affecting its supply of active pharmaceutical ingredients (APIs), on which it relies for...
10.01.2019
- Each year in March, the pharmaceutical manufacturing industry gathers in New York City for DCAT Week, and this year is no exception. DCAT Week ’19, the flagship event of the Drug...
23.08.2018
- After two years of trying, Israeli generics producer Teva Pharmaceutical Industries has finally gained approval by the US Food and Drug Administration (FDA) for its copy of Mylan’s...
12.07.2018
- French drugmaker Sanofi and private equity investor Advent International have agreed a deal under which Advent will acquire Sanofi's European generics business Zentiva for €1.9...
